Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Antigen-Specific Antibody Signature Is Associated with COVID-19 Outcome.
Salgado BB, Jordão MF, de Morais TBDN, da Silva DSS, Pereira Filho IV, Salgado Sobrinho WB, Carvalho NO, Dos Santos RO, Forato J, Barbosa PP, Toledo-Teixeira DA, Pinto KR, Correia IS, Cordeiro IB, Souza Neto JN, Assunção EN, Val FFA, Melo GC, Sampaio VS, Monteiro WM, Granja F, Souza WM, Astolfi Filho S, Proenca-Modena JL, Lalwani JDB, Lacerda MVG, Nogueira PA, Lalwani P. Salgado BB, et al. Among authors: carvalho no. Viruses. 2023 Apr 20;15(4):1018. doi: 10.3390/v15041018. Viruses. 2023. PMID: 37112998 Free PMC article.
Inhibition of extracellular traps by spores of Trichoderma stromaticum on neutrophils obtained from human peripheral blood.
Oliveira-Mendonça LS, de Sousa Lopes D, Bozzi A, Carvalho NO, Queiroz-Oliveira T, Santos Matos ME, de Carvalho AT, Castro-Gomes T, Mendes EA, Augusto DG, Bispo Sousa SM, Silva-Jardim I, Lima-Santos J. Oliveira-Mendonça LS, et al. Among authors: carvalho no. Mol Immunol. 2022 Jan;141:43-52. doi: 10.1016/j.molimm.2021.11.005. Epub 2021 Nov 16. Mol Immunol. 2022. PMID: 34798497
Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project.
Valim V, Martins-Filho OA, Gouvea MDPG, Camacho LAB, Villela DAM, de Lima SMB, Azevedo AS, Neto LFP, Domingues CMAS, de Medeiros Junior NF, Moulaz IR, Dias LH, Miyamoto ST, Teixeira-Carvalho A, Mill JG; Half Dose ChAdOx Study Group. Valim V, et al. Front Immunol. 2022 Aug 29;13:966416. doi: 10.3389/fimmu.2022.966416. eCollection 2022. Front Immunol. 2022. PMID: 36105814 Free PMC article. Clinical Trial.
SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study.
Lalwani P, Salgado BB, Filho IVP, da Silva DSS, de Morais TBDN, Jordão MF, Barbosa ARC, Cordeiro IB, Neto JNS, de Assunção EN, Dos Santos RO, Carvalho NO, Sobrinho WBS, da Costa CF, de Souza PE, de Albuquerque BC, Ganoza CA, Araujo-Castillo RV, Filho SA, Lalwani JDB; DETECTCoV-19 Study Team. Lalwani P, et al. Among authors: carvalho no. Int J Infect Dis. 2021 Sep;110:141-150. doi: 10.1016/j.ijid.2021.07.017. Epub 2021 Jul 14. Int J Infect Dis. 2021. PMID: 34273518 Free PMC article.